submit to the journals

Chronic Lymphocytic Leukemia Journal Articles, Videos And Insights

Chronic Lymphocytic Leukemia: FEATURED Articles


Chronic Lymphocytic Leukemia: Latest Articles

Chronic Lymphocytic Leukemia: INSIGHTS

The touchONCOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Meeting Proceedings
The Prognostic Significance of TP-53 Clone Size in Relapsed/Refractory CLL Patients in the MURANO Study Katrina Mountfort
Senior Medical Writer, Touch Medical Media, UK

Chronic Lymphocytic Leukemia: FEATURED VIDEOS

Editor's choice

Editor's choice coming soon..

Chronic Lymphocytic Leukemia: Latest Videos

Video List based on Category on Node Page

Latest Videos

touchONCOLOGY talks to Arnon P Kater from the Academisch Medisch Centrum Universiteit van Amsterdam about the MURANO study and the impact of TP53-mutated clone size on outcome of relapsed/refractory (R/R) CLL patients treated with venetoclax plus rituximab. 1. Why do chronic lymphocytic...
Editorial board member, Ian W Flinn from Sarah Cannon, Tennesse Oncology, in Nashville, TN, talks to us about risk of relapse and promising treatments for relapsed/refractory CLL and advances in the treatment of DLBCL and follicular lymphoma. 1. What are the most important unmet needs...
Dr. John Pagel discusses the explosion of new treatment options for chronic lymphocytic leukemia (CLL). Learn more about new biological therapies.
Dr Campo (University of Barcelona, Barcelona, Spain) talks to ecancertv at EHA 2014 about the genetics of CLL, with specific reference to ibrutinib and the RESONATE trial.
Prof Robin Foa, Dr Simon Rule and Dr Clemens Wendtner discuss the main highlights presented from the ASH 2013 meeting.
Prof Gribben (Queen Mary University London, London, UK) chairs a discussion with Prof Hillmen (St James’ University Hospital, Leeds, UK), and Prof Mulligan (Royal North Shore Hospital, St Leonards, Australia) about the advances in CLL.


Conference Highlights